Subscribe to RSS
DOI: 10.1055/s-0040-1704175
DIAGNOSTIC PERFORMANCE OF ENDOSCOPIC ULTRASOUND THROUGH-THE-NEEDLE MICROFORCEPS BIOPSY (EUS-TTNB) OF PANCREATIC CYSTIC LESIONS: A SYSTEMATIC REVIEW WITH META-ANALYSIS
Publication History
Publication Date:
23 April 2020 (online)
Aims Endoscopic ultrasound through-the-needle biopsy (EUS-TTNB) is a useful tool for differential diagnosis among pancreatic cystic lesions (PCLs). Cystic fluid cytology (CFC) is recommended by guidelines, but its diagnostic accuracy is about 50%. The aim of this meta-analysis is to assess the clinical impact of EUS-TTNB in terms of diagnostic capacity and accuracy.
Methods Observational studies on EUS-TTNB were searched in MEDLINE and EMBASE, until May 2019. Data on feasibility, histological accuracy (HA), diagnostic yield (DY) and adverse events (AEs) were extracted and pooled. Diagnostic accuracy of EUS-TTNB for identification of mucinous PCLs was calculated using individual diagnostic data of patients underwent CFC and surgery.
Results Nine studies including 454 patients underwent EUS-TTNB met the inclusion criteria for the meta-analysis. Feasibility and HA of EUS-TTNB were respectively 98.5% (95% Confidence Interval [CI] 97.3% - 99.6%) and 86.7% (95%CI 80.1-93.4). DY was 69.5% (95%CI 59.2-79.7) for EUS-TTNB and 28.7% (95%CI 15.7-41.6) for CFC. Heterogeneity persisted significantly high in most of subgroup analyses. In the multivariate meta-regression cyst size was independently associated with higher DY. Sensitivity and specificity for mucinous PCLs were 88.6 and 94.7% for EUS-TTNB, and 40 and 100% for CFC. AEs rate was 8.6% (95%CI 4.0-13.1).
Conclusions This meta-analysis shows that EUS-TTNB is a feasible technique that allows to obtain a high rate of adequate specimens for histology; in about two thirds of patients a specific histotype diagnosis could be assessed. The number of adverse events is slightly higher respect to standard EUS-FNA, but complications are very rarely severe.